Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis

Autor: Rima M. Saliba, Amin M. Alousi, Joseph Pidala, Mukta Arora, Stephen R. Spellman, Michael T. Hemmer, Tao Wang, Camille Abboud, Sairah Ahmed, Joseph H. Antin, Amer Beitinjaneh, David Buchbinder, Michael Byrne, Jean-Yves Cahn, Hannah Choe, Rabi Hanna, Peiman Hematti, Rammurti T. Kamble, Carrie L. Kitko, Mary Laughlin, Lazaros Lekakis, Margaret L. MacMillan, Rodrigo Martino, Parinda A. Mehta, Taiga Nishihori, Sagar S. Patel, Miguel-Angel Perales, Hemalatha G. Rangarajan, Olov Ringdén, Joseph Rosenthal, Bipin N. Savani, Kirk R. Schultz, Sachiko Seo, Takanori Teshima, Marjolein van der Poel, Leo F. Verdonck, Daniel Weisdorf, Baldeep Wirk, Jean A. Yared, Jeffrey Schriber, Richard E. Champlin, Stefan O. Ciurea

Publikováno v: Transplantation and Cellular Therapy, 28(10), 681-693. Elsevier

Post-transplantation cyclophosphamide (PTCy) has been shown to effectively control graft-versus-host disease (GvHD) in haploidentical (Haplo) transplantations. In this retrospective registry study, we compared GvHD organ distribution, severity, and o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::356fa5e8353cd467a9f1e9db90c4ac2c
https://doi.org/10.1016/j.jtct.2022.07.013

A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia

Autor: Carlos E. Vigil, Eunice S. Wang, María Belén Vidriales Vicente, Priyanka Mehta, David J. Bearss, Stephen P. Anthony, Joshua F. Zeidner, Andrew Dalovisio, Olga Frankfurt, M. Yair Levy, Richard Dillon, Mark R. Litzow, Tara L. Lin, Aziz Nazha, Pau Montesinos, Daniel J. Lee, Jeffrey Schriber, Teresa Bernal Del Castillo, Karen W.L. Yee, Jordi Esteve, Juan Miguel Bergua Burgues, Gil Fine, B. Douglas Smith, Bhavana Bhatnagar, Vijaya Raj Bhatt

Publikováno v: Blood Cancer Journal
BLOOD CANCER JOURNAL
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Blood Cancer Journal, Vol 11, Iss 10, Pp 1-5 (2021)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3942dd1e54bd08a10bcfddea324cde57
http://europepmc.org/articles/PMC8557202

Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma

Autor: Gunjan L. Shah, Sherif M. Badawy, Nosha Farhadfar, Jason Tay, Mohamed A. Kharfan-Dabaja, Shaji Kumar, Minoo Battiwalla, Sachiko Seo, Rebecca L. Olin, Kenneth R. Meehan, Parameswaran Hari, Richard F. Olsson, Pashna N. Munshi, Muzaffar H. Qazilbash, Maxwell M. Krem, Hemant S. Murthy, Artur Jurczyszyn, Anita D'Souza, Jeffrey Schriber, Saurabh Chhabra, Siddhartha Ganguly, Vaibhav Agrawal, Omar Davila, Melhem Solh, Taiga Nishihori, Hillard M. Lazarus, Ehsan Malek, Nina Shah, Andrew St. Martin, Jan Maciej Zaucha, Shahrukh K. Hashmi, David H. Vesole, Edward A. Copelan

Publikováno v: Cancer

BACKGROUND Upfront autologous hematopoietic stem cell transplantation (AHCT) remains an important therapy in the management of patients with multiple myeloma (MM), a disease of older adults. METHODS The authors investigated the outcomes of AHCT in pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad550a3a81613ed3b09f84affaf48a74
https://pubmed.ncbi.nlm.nih.gov/34254668

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors

Autor: David A. Jacobsohn, William T. Tse, Katharine E. Duckworth, Marcie L. Riches, Ruthee-Lu Bayer, Andrew S. Artz, J. Douglas Rizzo, Edward D. Ball, Indira Sahdev, Deidre M. Kiefer, Daniel J. Weisdorf, John P. Miller, Paolo Anderlini, Christopher C. Dvorak, Carolyn Bigelow, Shalini Shenoy, Michael L. Linenberger, Michael A. Pulsipher, Pintip Chitphakdithai, Brian J. Bolwell, Rebecca J. Drexler, David C. Delgado, Aly Abdel-Mageed, Jane L. Liesveld, Edmund K. Waller, E. Randolph Broun, Hillard M. Lazarus, Ann A. Jakubowski, O'Susan F Leitman, Margarida De Magalhaes-Silverman, Luke P. Akard, Willis H. Navarro, Gregory A. Yanik, Parameswaran Hari, Paul J. Shaughnessy, Galen E. Switzer, Shahram Mori, Witold B. Rybka, Vinod K. Prasad, Vinod Parameswaran, Joseph P. Uberti, Theresa Hahn, Ibrahim Ahmed, George B. Selby, Kimberly A. Kasow, Scott D. Rowley, Ann E. Haight, Brent R. Logan, Mark R. Litzow, Jeffrey Schriber, Dennis L. Confer, Thomas R. Spitzer, John M. McCarty, Hati Kobusingye, Madhuri Vusirikala, Bronwen E. Shaw, Brandon Hayes-Lattin, Walter L. Longo, Joseph P. McGuirk, RaeAnne M. Besser, Mary M. Horowitz

Publikováno v: Haematologica
Haematologica, vol 104, iss 4

Unlike unrelated donor registries, transplant centers lack uniform approaches to related donor assessment and deferral. To test whether related donors are at increased risk for donation-related toxicities, we conducted a prospective observational tri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::840bd2a98712b6d9d0d7cd7d8317324f
https://doi.org/10.3324/haematol.2018.200121

Acute Graft-Versus-Host Disease Is Less Severe and Associated with Lower Non-Relapse Mortality after Haploidentical Transplantation with Post-Cyclophosphamide Prophylaxis

Autor: Mukta Arora, Mary M. Horowitz, Michael T. Hemmer, Joseph Pidala, Margaret L. MacMillan, Stefan O. Ciurea, Stephen R. Spellman, Amin M. Alousi, Rima M. Saliba, Tao Wang, Jeffrey Schriber, Madan Jagasia, Richard E. Champlin

Publikováno v: Biology of Blood and Marrow Transplantation. 26:S26-S27

Introduction Haploidentical (HAPLO) stem cell transplantation (SCT) has been shown to be associated with lower incidence of severe acute graft-versus-host (aGVHD) compared with 8/8 HLA-matched unrelated donor (MUD) SCT. However, no information is ava

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9b747bee95190c42bd5276e4d1111ba4
https://doi.org/10.1016/j.bbmt.2019.12.095